Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Rosebank chairman raises stake

Fri 23 Oct 2026 12:51

(Sharecast News) - Rosebank Industries revealed on Friday that chairman Justin Dowley had acquired 161,576 ordinary shares in the FTSE 250-listed turnaround specialist. Dowley, who took over as chairman in 2024, purchased the shares at an average price of 308.68p each, for a total value of £498,748.61.

Following the transaction, Dowley holds a beneficial interest in 906,049 ordinary Rosebank shares.

As of 1410 BST, Rosebank shares were up 4.61% at 318p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Rosebank Industries Npv (ROSE) Director name: Dowley,Justin Amount purchased: 161,576 @ 308.68p Value: £498,748.61

Personal Assets Trust (PNL) Director name: Ferguson,Iain Amount purchased: 3,618 @ 549.91p Value: £19,895.88

Personal Assets Trust (PNL) Director name: Ferguson,Iain Amount purchased: 1,809 @ 549.91p Value: £9,947.91

Top Director Sells

Filtronic (FTC) Director name: Edington,Nat Amount sold: 2,100,000 @ 250.00p Value: £5,250,000.00

Yu Group (YU.) Director name: Rawson,Paul Amount sold: 60,000 @ 1,700.00p Value: £1,020,000.00

Share this article

Related Sharecast Articles

Thu 22 Oct 2026 14:42
Director dealings: IQE director snaps up shares
(Sharecast News) - IQE revealed on Thursday that non-executive director Robert Dennehy had acquired 468,817 ordinary shares in the AIM-listed semiconductor wafers and materials solutions supplier.
Wed 21 Oct 2026 14:25
Director dealings: Everyman Media's Dorfman snaps up shares
(Sharecast News) - Everyman Media revealed on Wednesday that interim creative director Charles Dorfman had acquired 925,000 ordinary shares in the AIM-listed cinema operator.
Tue 20 Oct 2026 15:00
Director dealings: Accler8 chairman raises stake
(Sharecast News) - Acceler8 Ventures revealed on Tuesday that chairman Nigel Rudd had acquired 121,429 ordinary shares in the London-listed life sciences business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statements | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026